• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植后合并眼内及全身使用利妥昔单抗治疗具有结外边缘区淋巴瘤样形态的眼淋巴增殖性疾病。

Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.

作者信息

Bata Bashar M, Pulido Jose S, Patel Sanjay V, Khan Shakila P, Salomao Diva, Boyce Thomas G, Bothun Erick D

机构信息

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Department of Pediatric and Adolescent Medicine, Division of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota.

出版信息

J AAPOS. 2018 Apr;22(2):159-161. doi: 10.1016/j.jaapos.2017.10.016. Epub 2018 Apr 3.

DOI:10.1016/j.jaapos.2017.10.016
PMID:29408337
Abstract

Post-transplant lymphoproliferative disorder (PTLD) has rarely been associated with ocular manifestations. We report a case of bilateral ocular involvement by PTLD with histopathologic features of extranodal marginal zone (MALT) lymphoma in an 8-year-old boy following orthotopic heart transplantation. The anterior segment disease was treated successfully using a combination of intraocular and systemic injections of humanized anti-CD20 antibody (rituximab).

摘要

移植后淋巴组织增生性疾病(PTLD)很少伴有眼部表现。我们报告一例8岁男孩原位心脏移植后发生的PTLD双侧眼部受累病例,其组织病理学特征为结外边缘区(MALT)淋巴瘤。前段疾病通过眼内及全身注射人源化抗CD20抗体(利妥昔单抗)联合治疗成功治愈。

相似文献

1
Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.心脏移植后合并眼内及全身使用利妥昔单抗治疗具有结外边缘区淋巴瘤样形态的眼淋巴增殖性疾病。
J AAPOS. 2018 Apr;22(2):159-161. doi: 10.1016/j.jaapos.2017.10.016. Epub 2018 Apr 3.
2
Successful treatment of intraocular post-transplant lymphoproliferative disorder with intravenous rituximab.
Pediatr Blood Cancer. 2015 Jan;62(1):169-72. doi: 10.1002/pbc.25223. Epub 2014 Aug 31.
3
Intralesional rituximab for primary iris lymphoma.病灶内注射利妥昔单抗治疗原发性虹膜淋巴瘤。
JAMA Ophthalmol. 2015 Jan;133(1):104-5. doi: 10.1001/jamaophthalmol.2014.3303.
4
Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.肺黏膜相关淋巴组织结外边缘区B细胞淋巴瘤:一例报告及文献复习
Niger J Clin Pract. 2018 Mar;21(3):392-394. doi: 10.4103/njcp.njcp_393_16.
5
[Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].[移植后淋巴组织增生性疾病:15例临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):607-12. doi: 10.3760/cma.j.issn.0529-5807.2012.09.008.
6
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.减少免疫抑制联合全脑放疗和同期全身利妥昔单抗治疗原发性中枢神经系统移植后淋巴组织增生性疾病(pCNS-PTLD):来自前瞻性德国 PTLD 登记处的 14 例病例。
Ann Hematol. 2021 Aug;100(8):2043-2050. doi: 10.1007/s00277-021-04548-2. Epub 2021 May 11.
7
EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?移植后环境中的 EBV 阳性结外黏膜边缘区淋巴瘤:一种独特的移植后淋巴增殖性疾病?
Am J Surg Pathol. 2011 Jun;35(6):807-15. doi: 10.1097/PAS.0b013e3182190999.
8
Primary ocular posttransplant lymphoproliferative disease.
J Pediatr Ophthalmol Strabismus. 1995 Nov-Dec;32(6):393-4. doi: 10.3928/0191-3913-19951101-16.
9
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).抗CD20抗体利妥昔单抗在移植后淋巴细胞增生性疾病(PTLD)患者中的疗效。
Am J Transplant. 2005 Dec;5(12):2901-6. doi: 10.1111/j.1600-6143.2005.01098.x.
10
A patient with primary Sjogren's syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.原发性干燥综合征、肺囊性疾病和边缘区淋巴瘤患者成功接受利妥昔单抗治疗:基于病例的综述。
Clin Rheumatol. 2020 Apr;39(4):1357-1362. doi: 10.1007/s10067-019-04886-7. Epub 2019 Dec 20.

引用本文的文献

1
Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma.玻璃体视网膜淋巴瘤在一名弥漫性大B细胞淋巴瘤患者中表现为霜样树枝状视网膜血管炎。
Am J Ophthalmol Case Rep. 2023 Mar 31;30:101838. doi: 10.1016/j.ajoc.2023.101838. eCollection 2023 Jun.
2
Ultra-low-dose (boom-boom) radiotherapy for management of recurrent ocular post-transplant lymphoproliferative disorder.超低剂量(砰砰)放疗用于复发性眼部移植后淋巴组织增生性疾病的治疗
Am J Ophthalmol Case Rep. 2021 May 15;23:101118. doi: 10.1016/j.ajoc.2021.101118. eCollection 2021 Sep.
3
Primary central nervous system lymphoma after heart transplantation: A case report and literature review.
心脏移植术后原发性中枢神经系统淋巴瘤:一例报告并文献复习
Medicine (Baltimore). 2020 Aug 28;99(35):e21844. doi: 10.1097/MD.0000000000021844.
4
Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder.EB 病毒阴性边缘区淋巴瘤作为一种罕见的单形性移植后淋巴组织增生性疾病。
Am J Surg Pathol. 2020 Oct;44(10):1340-1352. doi: 10.1097/PAS.0000000000001514.